0001104659-23-053018.txt : 20230428
0001104659-23-053018.hdr.sgml : 20230428
20230428162310
ACCESSION NUMBER: 0001104659-23-053018
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230428
FILED AS OF DATE: 20230428
DATE AS OF CHANGE: 20230428
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: EBSWORTH DAVID R
CENTRAL INDEX KEY: 0001207107
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38067
FILM NUMBER: 23866765
MAIL ADDRESS:
STREET 1: C/O CURAGEN CORP
STREET 2: 555 LONG WHARF DR. 11TH FL.
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Verona Pharma plc
CENTRAL INDEX KEY: 0001657312
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 MORE LONDON RIVERSIDE
CITY: LONDON
STATE: X0
ZIP: SE1 2RE
BUSINESS PHONE: 011-44-0-2032834200
MAIL ADDRESS:
STREET 1: 3 MORE LONDON RIVERSIDE
CITY: LONDON
STATE: X0
ZIP: SE1 2RE
4
1
tm2314094-7_4seq1.xml
OWNERSHIP DOCUMENT
X0407
4
2023-04-28
0
0001657312
Verona Pharma plc
VRNA
0001207107
EBSWORTH DAVID R
3 MORE LONDON RIVERSIDE
LONDON
X0
SE1 2RE
UNITED KINGDOM
1
0
0
0
0
Share Options (Right to Buy)
2.67
2023-04-28
4
A
0
96000
0
A
2033-04-27
Ordinary Shares
96000
96000
D
The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
The option vests and becomes exercisable as to 25% on each of July 28, 2023, October 28, 2023, January 28, 2024 and April 28, 2024.
/s/ Claire Poll, Attorney-in-fact for David R. Ebsworth
2023-04-28